Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-655-7 | CAS number: -
Endpoint summary
Administrative data
Description of key information
A key study was available for read-across substance CAS 68784 -08 -7 according to the Magnusson and Kligman Maximisation Test in guinea pigs. Induction with 0.5% suspension (intracutaneous) and 2 mL of a 25% suspension, followed by challenge with 2 mL of a 10% suspension of the test item - the maximum non-irritating concentration - revealed no skin irritation in any animal and, thus, the test item had no sensitising properties.
Key value for chemical safety assessment
Skin sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
Guinea-pig maximisation testing
Read-across substance CAS 68784 -08 -7 (test item containing 39.80% active ingredient) was tested for its sensitising properties in the Magnusson and Kligman Maximisation Test in guinea pigs (Haferkorn, 2013c). A 0.5% suspension in aqua ad iniectabilia chosen for the 1st (intracutaneous) induction stage revealed a discrete or patchy erythema in all 10 animals 24 and 48 hours after administration. 2 mL of a 25% suspension of the test item in aqua ad iniectabilia/animal chosen for the 2nd (topical) induction stage revealed a moderate and confluent erythema 48 hours and a discrete or patchy erythema 72 hours after start of exposure in all 10 animals. The challenge with 2 mL of a 10% suspension of the test item in aqua ad iniectabilia /animal - the maximum non-irritating concentration - revealed no skin irritation in any animal and, thus, the test item had no sensitising properties. The vehicle control revealed no skin reactions. Animals of the same strain treated with α-hexyl cinnamic aldehyde in sesame oil exhibited a sensitising reaction in all animals in form of a moderate and confluent erythema (grade 2).
Behaviour of the animals remained unchanged. Body weights were not influenced.
In conclusion, under the present test conditions, test item containing 39.80% active ingredient, was found to be not sensitising to guinea pigs in a test model according to MAGNUSSON and KLIGMAN.
Conclusion
- Based on the negative findings in the guinea-pig maximisation test, potential for skin sensitisation can be excluded.
- Further information supporting the absence of sensitisation potential is also provided in the read across justification for the N2 subgroup, showing that other guinea-pig maximisation was also negative. (Justification with data matrix separately attached in Section 13).
Justification for selection of skin sensitisation endpoint: Key study
Justification for classification or non-classification
As there was no indication for sensitisation from the Guinea-pig Maximisation test, classification for skin sensitisation is not needed according to the EC CLP Guidance (No. 1272/2008 of 16 December 2008).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Route: .live2